MoneyWorks4Me

Lupin informs about press release

30 Jul 2021 Evaluate

In compliance with Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, Lupin has informed that it attached a Press Release on 30th July 2021 regarding acquisition of Southern Cross Pharma, Australia.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..